BioSpace News Archive

Biotech Bay

Silver Bullet Therapeutics Secures CE Mark Approval for Revolutionary New Antimicrobial Bone Screw System

Silver Bullet Therapeutics, Inc., a privately-held medical device company, announced today that it has received recommendation for CE Mark approval for the commercial sale of its antimicrobial OrthoFuzIon™ Bone Screw System in the European Union for orthopedic reduction and internal fixation procedures anywhere in the body.

January 9, 2020
·
3 min read
Business

Rafarma Adds Thai Corporate Officer to Solidify Market Entry in Thailand Cannabis Industry

Rafarma Pharmaceuticals, Inc. is pleased to welcome a new Executive Vice-President for Thai operations, Mr. Anucha Phetpheng. Mr. Phetpheng, 55, resides both in Bangkok and Phuket, Thailand with his wife and three children.

January 9, 2020
·
1 min read
FDA

FDA approves the first targeted therapy to treat a rare mutation in patients with gastrointestinal stromal tumors

Ayvakit is a kinase inhibitor, meaning it blocks a type of enzyme called a kinase and helps keeps the cancer cells from growing.

January 9, 2020
·
4 min read
Pharm Country

Prevail Therapeutics Provides PR001 Program Update

Prevail Therapeutics Inc. (Nasdaq: PRVL) (“Prevail” or the “Company”), a biotechnology company developing potentially disease-modifying AAV-based gene therapies for patients with neurodegenerative diseases, today provided an update on its investigational program, PR001, an AAV9-based gene therapy delivering the GBA1 gene, for the neuronopathic Gaucher disease (nGD) indication.

January 9, 2020
·
4 min read
Business

NeuBase Therapeutics Reports Financial Results for Fiscal Year 2019Expects to report preclinical PK and PD data for the PATrOL™ platform and PATrOL-enabled candidates beginning in Q1 and in Q2 of calendar year 2020

NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase” or the “Company”), a biotechnology company developing next-generation antisense therapies using its scalable PATrOL™ platform to address genetic diseases, today reported its financial results for the fiscal year ended September 30, 2019.

January 9, 2020
·
9 min read
Business

Neural Analytics Appoints Diane M. Bryant as Chairman and CEO

Neural Analytics, Inc., a medical robotics company developing and commercializing technologies to measure and track brain health, announced it has appointed former Google Cloud COO Diane M. Bryant as Chairman and CEO, effective immediately.

January 9, 2020
·
3 min read
Ascendis Pharma A/S Announces Participation in 38th Annual J.P. Morgan Healthcare Conference

Ascendis Pharma A/S, a biopharmaceutical company that utilizes its innovative TransCon™ technologies to address unmet medical needs, announced that the company will participate in the upcoming 38th Annual J.P. Morgan Healthcare Conference.

January 9, 2020
·
4 min read
Drug Development

Ultragenyx Announces Positive Topline Cohort 3 Results and Improved Longer-Term Cohort 2 Results from Phase 1/2 Study of DTX301 Gene Therapy in Ornithine Transcarbamylase (OTC) Deficiency

More uniform response in Cohort 3 with two confirmed responders and one potential responder

January 9, 2020
·
9 min read
Deals

Matinas BioPharma Announces Proposed Public Offering of Common Stock - Jan. 09, 2020

Matinas BioPharma Holdings, Inc. announced that it has commenced an underwritten public offering of its common stock.

January 9, 2020
·
4 min read
Biotech Bay

Amgen To Present At The 38th Annual J.P. Morgan Healthcare Conference

Amgen (NASDAQ:AMGN) will present at the 38th Annual J.P. Morgan Healthcare Conference at 8:30 a.m. PT on Tuesday, Jan. 14, 2020, in San Francisco.

January 9, 2020
·
1 min read